Your session is about to expire
← Back to Search
Behavioral Intervention
CBT4CBT-Buprenorphine + Recovery Coach for Opioid Use Disorder
N/A
Waitlist Available
Research Sponsored by Prisma Health-Upstate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 and 3 month follow up
Awards & highlights
Study Summary
This study is evaluating whether a combination of cognitive behavioral therapy and buprenorphine may help individuals with opioid use disorder.
Eligible Conditions
- Opioid Use Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 and 3 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 and 3 month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Change in drug use
Retention to buprenorphine
Other outcome measures
Cognitive performance through Electroencephalogram
Commission errors
Selective attention
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CBT4CBT-Buprenorphine + Recovery CoachExperimental Treatment1 Intervention
This condition will consist of the CBT4CBT-Buprenorphine intervention alongside weekly coaching sessions from a recovery professional
Group II: Standard Treatment As Usual (TAU)Active Control1 Intervention
Participants in the standard of care condition will receive the standard treatment at the recovery program, which consists of weekly or bi-weekly visits (at the discretion of the provider) to the clinic to meet with their provider and provide a sample of blood.
Find a Location
Who is running the clinical trial?
Prisma Health-UpstateLead Sponsor
83 Previous Clinical Trials
42,968 Total Patients Enrolled
Clemson UniversityOTHER
34 Previous Clinical Trials
5,923 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger